EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Re: ‘Real world clinical outcome of cefiderocol for treatment of multidrug-resistant nonfermenting gram-negative bacilli infections' by Hoellinger et al.

Romaric Larcher, Paul Laffont-Lozes, Paul Loubet, Didier Laureillard, Tayma Naciri, Albert Sotto

Clinical Microbiology and Infection · 2023

DOI: 10.1016/j.cmi.2023.01.022 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Clinical Microbiology and Infection, 2023. Verfasst von Romaric Larcher und 5 weiteren Autor:innen. Beteiligte Einrichtung: PhyMedExp (Physiology and Experimental Medicine), INSERM (French Institute of Health and Medical Research), CNRS (French National Centre for Scientifi…. Hauptthemen laut MEDLINE: Cephalosporins, Gram-Negative Bacterial Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CephalosporinsGram-Negative Bacterial InfectionsHumansAnti-Bacterial AgentsGram-Negative BacteriaMicrobial Sensitivity TestsDrug Resistance, Multiple, BacterialCefiderocol

Stichwörter der Autor:innen

Antimicrobial susceptibility testingBloodstream infectionCefiderocolCombination therapyHeteroresistanceImmunocompromised patientNonfermenters. outcomes

Substanzen

CephalosporinsAnti-Bacterial AgentsCefiderocol

Autor:innen und Institutionen

  • PhyMedExp (Physiology and Experimental Medicine), INSERM (French Institute of Health and Medical Research), CNRS (French National Centre for Scientific Research), University of Montpellier, France and Department of Infec…
  • Department of Infectious and Tropical Diseases and Department of Pharmacy, Nîmes University Hospital, France.
  • VBIC (Bacterial Virulence and Chronic Infection), INSERM (French Institute of Health and Medical Research), Montpellier University, Department of Infectious and Tropical Diseases, Nîmes University Hospital, France.
  • Department of Infectious and Tropical Diseases, Nîmes University Hospital, France.

Zitieren

APA

Larcher, R., Laffont-Lozes, P., Loubet, P., Laureillard, D., Naciri, T., & Sotto, A. (2023). Re: ‘Real world clinical outcome of cefiderocol for treatment of multidrug-resistant nonfermenting gram-negative bacilli infections' by Hoellinger et al. Clinical Microbiology and Infection. https://doi.org/10.1016/j.cmi.2023.01.022

Vancouver

Larcher R, Laffont-Lozes P, Loubet P, Laureillard D, Naciri T, Sotto A. Re: ‘Real world clinical outcome of cefiderocol for treatment of multidrug-resistant nonfermenting gram-negative bacilli infections' by Hoellinger et al. Clinical Microbiology and Infection. 2023. doi:10.1016/j.cmi.2023.01.022

BibTeX
@article{Larcher2023,
  author = {Larcher, Romaric and Laffont-Lozes, Paul and Loubet, Paul and Laureillard, Didier and Naciri, Tayma and Sotto, Albert},
  title = {Re: ‘Real world clinical outcome of cefiderocol for treatment of multidrug-resistant nonfermenting gram-negative bacilli infections' by Hoellinger et al},
  journal = {Clinical Microbiology and Infection},
  year = {2023},
  doi = {10.1016/j.cmi.2023.01.022}
}
Kostenlos starten →